RETINAL VEIN OCCLUSION
Clinical trials for RETINAL VEIN OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new RETINAL VEIN OCCLUSION trials appear
Sign up with your email to follow new studies for RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel could make eye injections Pain-Free
Symptom relief ENROLLING_BY_INVITATIONThis study compares a new numbing gel (chloroprocaine HCl 3%) to standard eye drops plus a shot for pain relief during eye injections. About 236 adults with conditions like diabetic macular edema or age-related macular degeneration will take part. The goal is to see if the gel wo…
Matched conditions: RETINAL VEIN OCCLUSION
Phase: PHASE4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Massive Real-World study tracks roche eye drugs in 6,000 patients
Knowledge-focused OngoingThis study is collecting long-term, real-world data from about 6,000 adults being treated with Roche eye medications (Faricimab or the Port Delivery System with Ranibizumab) for conditions like wet age-related macular degeneration and diabetic macular edema. The goal is to unders…
Matched conditions: RETINAL VEIN OCCLUSION
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New study tracks Faricimab's Real-World impact on major eye diseases
Knowledge-focused OngoingThis study follows 1,000 patients in China who are already receiving faricimab for diabetic macular edema, retinal vein occlusion, or wet age-related macular degeneration. Researchers will collect data from routine clinic visits over one year to see how well the drug works and ho…
Matched conditions: RETINAL VEIN OCCLUSION
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC